Literature DB >> 8360732

Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury.

T Shiozaki1, H Sugimoto, M Taneda, H Yoshida, A Iwai, T Yoshioka, T Sugimoto.   

Abstract

Recent experimental studies have demonstrated that mild hypothermia at about 34 degrees C can be effective in the control of intracranial hypertension. A randomized controlled study of mild hypothermia was carried out in 33 severely head-injured patients. All patients fulfilled the following criteria: 1) persistent intracranial pressure (ICP) greater than 20 mm Hg despite fluid restriction, hyperventilation, and high-dose barbiturate therapy; 2) an ICP lower than the mean arterial blood pressure; and 3) a Glasgow Coma Scale score of 8 or less. The patients were divided into two groups: one received mild hypothermia (16 patients) and one served as a control group (17 patients). Mild hypothermia significantly reduced the ICP and increased the cerebral perfusion pressure. Eight patients (50%) in the hypothermia group and three (18%) in the control group survived (p < 0.05), while five (31%) in the hypothermia group and 12 (71%) in the control group died of uncontrollable intracranial hypertension (p < 0.05). In five patients in the hypothermia group, cerebral blood flow was measured by the hydrogen clearance method and arteriojugular venous oxygen difference was evaluated before and during mild hypothermia. Mild hypothermia significantly decreased the cerebral blood flow, arteriojugular venous oxygen difference, and cerebral metabolic rate of oxygen (p < 0.01). The results of this preliminary investigation suggest that mild hypothermia is a safe and effective method to control traumatic intracranial hypertension and to improve mortality and morbidity rates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360732     DOI: 10.3171/jns.1993.79.3.0363

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  66 in total

Review 1.  Pediatric neurocritical care.

Authors:  Sarah Murphy
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  [Therapeutic hypothermia after cardiac arrest].

Authors:  E Popp; F Sterz; B W Böttiger
Journal:  Anaesthesist       Date:  2005-02       Impact factor: 1.041

Review 3.  [Controlled mild-to-moderate hypothermia in the intensive care unit].

Authors:  A Brüx; A R J Girbes; K H Polderman
Journal:  Anaesthesist       Date:  2005-03       Impact factor: 1.041

4.  Statins in acute brain injury: getting the cart before the horse.

Authors:  Daniel T Laskowitz; David S Warner
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 5.  [Therapeutic hypothermia in the intensive care unit].

Authors:  J Meixensberger; C Renner
Journal:  Anaesthesist       Date:  2007-09       Impact factor: 1.041

Review 6.  Trends in neuroanaesthesia.

Authors:  J E Cottrell
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

7.  Therapeutic hypothermia for neuroprotection: history, mechanisms, risks, and clinical applications.

Authors:  Lioudmila V Karnatovskaia; Katja E Wartenberg; William D Freeman
Journal:  Neurohospitalist       Date:  2014-07

8.  Intracerebral hemorrhage: clinical overview and pathophysiologic concepts.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Transl Stroke Res       Date:  2012-04-21       Impact factor: 6.829

9.  Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial.

Authors:  D James Cooper; Alistair D Nichol; Michael Bailey; Stephen Bernard; Peter A Cameron; Sébastien Pili-Floury; Andrew Forbes; Dashiell Gantner; Alisa M Higgins; Olivier Huet; Jessica Kasza; Lynne Murray; Lynette Newby; Jeffrey J Presneill; Stephen Rashford; Jeffrey V Rosenfeld; Michael Stephenson; Shirley Vallance; Dinesh Varma; Steven A R Webb; Tony Trapani; Colin McArthur
Journal:  JAMA       Date:  2018-12-04       Impact factor: 56.272

10.  Management of hepatic encephalopathy.

Authors:  Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.